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Abstract
Background: Accumulating evidence suggests that glial signalling is activated by different brain functions.
However, knowledge regarding molecular mechanisms of activation or their relation to neuronal activity is limited.
The purpose of the present study is to identify the characteristics of ATP-evoked glial signalling in the brain reward
area, the nucleus accumbens (NAc), and thereby to explore the action of citric acid cycle intermediate succinate
(SUC).
Results: We described the burst-like propagation of Ca
2+ transients evoked by ATP in acute NAc slices from rat
brain. Co-localization of the ATP-evoked Ca
2+ signalling with immunoreactivities of the astroglia-specific gap
junction forming channel protein connexin43 (Cx43) and the glial fibrillary acidic protein (GFAP) indicated that the
responsive cells were a subpopulation of Cx43 and GFAP immunoreactive astrocytes. The ATP-evoked Ca
2+
transients were present under the blockade of neuronal activity, but were inhibited by Ca
2+ store depletion and
antagonism of the G protein coupled purinergic P2Y1 receptor subtype-specific antagonist MRS2179. Similarly, Ca
2+
transients evoked by the P2Y1 receptor subtype-specific agonist 2-(Methylthio)adenosine 5’-diphosphate were also
blocked by MRS2179. These characteristics implied that intercellular Ca
2+ signalling originated from the release of
Ca
2+ from internal stores, triggered by the activation of P2Y1 receptors. Inhibition by the gap junction blockers
carbenoxolone and flufenamic acid and by an antibody raised against the gating-associated segment of Cx43
suggested that intercellular Ca
2+ signalling proceeded through gap junctions. We demonstrated for the first time
that extracellular SUC also evoked Ca
2+ transients (EC50 = 50-60 μM) in about 15% of the ATP-responsive NAc
astrocytes. By contrast to glial cells, electrophysiologically identified NAc neurons surrounded by ATP-responsive
astrocytes were not activated simultaneously.
Conclusions: We concluded, therefore, that ATP- and SUC-sensitive Ca
2+ transients appear to represent a signalling
layer independent of NAc neurons. This previously unrecognised glial action of SUC, a major cellular energy
metabolite, may play a role in linking metabolism to Ca
2+ signalling in astrocytic networks under physiological and
pathological conditions such as exercise and metabolic diseases.
Background
In astrocytes of the brain reward area, the nucleus
accumbens (NAc; [1]), g-hydroxybutyric acid (GHB; [2])
evoked intracellular store-reliant Ca
2+ transients, inde-
pendently of neuronal activity [3]. Previously, we also
showed that binding sites for GHB are shared with citric
acid cycle intermediate succinic acid (SUC) and the gap-
junction blocker carbenoxolone hemisuccinate (CBX), as
disclosed in NAc membrane homogenates isolated from
rat and human brain tissues [4-6]. These findings raised
the possibility that SUC, similarly to GHB may also
evoke Ca
2+ transients in NAc astrocytes. Further, it is
conceivable that the rather specific sensitivity of the
SUC/GHB target site to CBX might be a sign of its
functional association with connexin channels. In order
to study the effect and functional significance of SUC
on the Ca
2+ homeostasis of NAc astrocytes, we consid-
ered that the Ca
2+ bursting activity was found ATP-
responsive in vivo, i.e. in Bergmann glia networks
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[7]. Therefore, we sought to characterise first the ATP-
responsive Ca
2+ signalling amongst the astrocytes of the
NAc.
ATP is known to evoke Ca
2+ bursts by activation of
purinergic G-protein-coupled receptors (GPCRs) in vitro
[8-10] as well as in vivo [7,11-13]. Different in vitro
paradigms, including locally administered ATP stimuli
(100 μM) were found effective to evoke Ca
2+ transients
[14-18]. In the present study, we investigated if locally
ejected ATP (100 μM) could evoke Ca
2+ bursting in
NAc astrocytes. Measurements were performed by com-
bined application of confocal Ca
2+ imaging, immunohis-
tochemistry and electrophysiology in acute NAc tissue
slices prepared from the rat brain. Astrocytes were iden-
tified by co-localization of astrocyte-specific antibodies
raised against the astroglial gap-junction protein con-
n e x i n4 3( C x 4 3 )a n dt h eg l i a lf i b r i l l a r ya c i d i cp r o t e i n
(GFAP). Then, ATP-evoked Ca
2+ bursts have been char-
acterised by using of various drugs and agents, including
gap-junction inhibitors (CBX, flufenamic acid: FFA), an
antibody raised against the gating peptide segment of
Cx43, purinergic P2 receptor agents such as the broad-
spectrum P2X and P2Y receptor antagonist suramin
(SUR), P2Y1 subtype-specific agonist 2-(Methylthio)ade-
nosine 5’-diphosphate (2-Me-S-ADP) and antagonist
MRS2179, the Na
+ channel blocker tetrodotoxin (TTX)
and the Ca
2+ store depleting cyclopiazonic acid (CPA).
M o r e o v e r ,w ea l s od e m o n s t r a t ef o rt h ef i r s tt i m et h e
existence of SUC-responsive Ca
2+ transients that overlay
in a sub-population of NAc astrocytes.
Results
In selecting the NAc region of interest, we first consid-
ered area-dependent distribution of Cx43 protein and its
co-localization with GFAP. Next, we asked if Cx43-posi-
tive NAc astrocytes were responded to local administra-
tion of ATP by Ca
2+ transients. Subsequently, the
hypothesis that SUC may also activate Ca
2+ transients
playing part in the ATP-responsive Ca
2+ signals was
tested. Finally, responsiveness of NAc neurons to ATP
was explored.
Demonstration of ATP-evoked burst-like Ca
2+ signals
amongst astrocytes in the NAc
The expression and distribution of Cx43 have been first
characterised in rat brain sections by immunohisto-
chemistry. The staining pattern in a coronal section of a
paraformaldehyde (PFA)-fixed rat brain revealed intense
staining in both the shell and the core regions in the
NAc (Figure 1A). High intensity of Cx43 immunolabel-
ling was observed in the NAc as compared to adjacent
brain regions (including the caudate putamen), suggest-
ing a relatively higher level of connectivity of the astro-
cyte network in the NAc through this type of gap-
junctions. Besides the NAc, relatively high Cx43 immu-
nolabelling was also found in other brain areas, includ-
ing several viscerosensory and limbic regions: i) medial
Figure 1 Cx43 is present in GFAP-containing astrocytes in the NAc. A: Cx43 immunoreactivity in a coronal section of a PFA-fixed rat brain
shows relatively high intensity in the NAc, as compared to adjacent brain regions. Abbreviations: ac - anterior commissure, CP caudate-putamen,
LS - lateral septal nucleus, LV - lateral ventricle, NAc - nucleus accumbens, VP - ventral pallidum. Scale bar: 1 mm. B: Comparison of the
appearance of Cx43 (red) and GFAP (green) proteins in the NAc. Low magnification (scale bar: 400 μm) confocal photomicrograph of a double
labelled section of a PFA-fixed rat brain. Co-localization (yellow) of Cx43 (red) and GFAP (green) immunoreactivities in the NAc suggests that
Cx43 is present in GFAP-containing astrocytes in this brain region. Label “x” indicates the site of ATP application. C: High magnification (scale bar:
20 μm) confocal photomicrograph of a double labelled section of a PFA-fixed rat brain. Yellow colour indicates co-localizations of Cx43 (red) and
GFAP (green) immunoreactivities in the PFA-fixed NAc.
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Page 2 of 17prefrontal cortex, ii) Purkinje cell layer of the cerebellar
cortex, iii) hippocampus, particularly the molecular layer
of the dentate gyrus, iv) central nucleus of the amygdala,
v) dorsal subdivision of the lateral septal nucleus, vi)
dorsolateral subdivision of the periaqueductal gray, and
vii) nucleus of the solitary tract (data not shown). Cx43
had a patchy distribution in the NAc; that is, areas with
high and low intensity of labelling were intermingled
(Figure 1B). Where the labelling of Cx43 was intense,
the vast majority of Cx43 cells contained astrocyte mar-
ker protein GFAP immunoreactivity as shown in Figure
1C.
In freshly prepared NAc slices from 10-14 day old
male rats, 100 μM ATP applied locally for 60 sec (long
ATP-puff) evoked Ca
2+ transients, propagating in up to
127 cells (44 ± 25 in average) in a total of 212 slices
from 53 rats (Figure 2A, additional file 1). In order to
characterise the dynamics of Ca
2+ transients, short (2 s,
Figure 2B left and middle) and long ATP (60 s, Figure
2B right) puffs were compared. The period of repetitive
Ca
2+ transients observed after the application of the
short ATP-puff (2 s) occurred on a time scale similar to
that of the bulky Ca
2+ transient evoked by the long
ATP-puff (Figure 2C). The observation suggested that
the bulky Ca
2+ signal can be decomposed into many
repetitive Ca
2+ transients providing kinetic evidence for
a burst-like, coupled Ca
2+ dynamics. The number of
ATP responsive astrocytes was significantly higher in
the NAc compared to the adjacent ventral pallidal area
(Figure 2D). In line with the Cx43 expression pattern
(Figure 1), the observation conjectured Cx43-related
ATP-responsive Ca
2+ signalling in the NAc. The burst-
like Ca
2+ signal, apparently not influenced by the direc-
tion of the perfusion, propagated in round or ellipsoidal
waveform at an approximate 10 μm/s speed (Figure 2A,
Additional file 1). When monitored by the glial marker
dye SR101 [19,20], the diffusion of ATP was about 1.5
times faster than the speed of the Ca
2+ wave propaga-
tion (Figure 2B left and middle). It is to note, that the
dynamics of burst-like Ca
2+ signals of NAc astrocytes
can be compared with that of Ca
2+ bursts of Bergmann
glia in vivo [7,13].
Molecular dissection of ATP-evoked burst-like Ca
2+
signalling
In the lack of specific gap-junction blocker, we applied
an antibody against the gating peptide segment of Cx43
[21] to inhibit Cx43 function and therefore to evaluate
the involvement of gap-junctions in the ATP-evoked
burst-like Ca
2+ signals. Few co-localization of Ca
2+ tran-
sients and Cx43 immunoreactivity was observed when
NAc slices were pre-incubated with the Cx43 antibody
(7.5 ± 2.3% of the ATP responsive cells; N =6f r o m2
rats), suggesting that inhibition of Cx43 function may
preclude Cx43 immunoreactive astrocytes to participate
in the Ca
2+ signal. In contrast, an about fourfold
increase in co-localization of Ca
2+ transients and Cx43
immunoreactivity was seen (Figure 3; 31 ± 3% of the
ATP responsive cells; N =4f r o m4r a t s ) ,w h e nt h e
same antibody was applied after the application of ATP
(cf. Materials and Methods). This observation indicated
that the blockade of the gap-junction could prevent
ATP from evoking burst-like Ca
2+ signalling. Co-locali-
zations of Ca
2+ transients with Cx43 (Figure 3) and
those of Cx43 with GFAP (Figure 1B) conclusively sug-
gested that the ATP-evoked burst-like Ca
2+ signalling
occurred in NAc astrocytes.
In order to characterise the molecular determinants of
ATP-evoked burst-like propagation of Ca
2+ transients,
effects of different gap-junction inhibitors (CBX, FFA),
purinergic P2 antagonists (SUR, MRS2179), agonist 2-
Me-S-ADP and Ca
2+ store depleting conditions (zero-
added Ca
2+ with or without CPA) were investigated. To
start with, the number of cells participating in the first
(100 μMA T P )a n dt h es e c o n d( 1 0 0μMA T Pp l u st e s t
compound) ATP applications were compared (Figure
4A and the Methods section). The changes in the num-
ber of ATP responsive cells in the presence of the test
compounds (ΔN) were compared to the ΔNv a l u e s
obtained for two consecutive ATP applications both in
the absence of test compounds (control), and were given
as percentage of the first ATP application (for details of
the applied drug testing protocol see also the Methods
section). Matching with affinities to those reported for
the blockade of intercellular communication through
gap junctions [22], ATP-evoked Ca
2+ signalling was sig-
nificantly inhibited by 100 μMa n d1m MC B X( N =1 4
from 11 rats). FFA applied in 1 mM concentration was
also found effective (N = 3 from 1 rat, Figure 4A left).
The voltage-gated Na
+ channel-blocking agent TTX (10
μM, N = 4 from 2 rats) and the broad spectrum P2X
and P2Y antagonist SUR (100 μM, N =5f r o m4r a t s ;1
mM, N = 3 from 1 rat) were ineffective. However, the
ATP puff-evoked Ca
2+ transients were virtually elimi-
nated by the selective P2Y1 receptor antagonist
MRS2179 (100 μM, N = 9 from 4 rats) (Figure 4A left).
The observed variability in MRS2179 effects most prob-
ably reflects the receptor/cell heterogeneity in the NAc
slices prepared from 10-14 day old rats. Noteworthy,
ATP only activated MRS2179-sensitive P2Y1 receptor in
the olfactory bulb [23], as well. Locally applied P2Y1
selective agonist 2-Me-S-ADP (10 μM, long puff; N =6
from 3 rats) also evoked Ca
2+ transients in cells loaded
with Fluo-4 acetoxymethyl ester (Fluo-4 AM), indicating
the involvement of P2Y1 receptor in Ca
2+ signalling
mechanisms within NAc astrocytes (Figure 4A right). In
addition, 100 μM MRS2179 also blocked Ca
2+ transients
evoked by 2-Me-S-ADP applied as ATP (Figure 4A
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Page 3 of 17Figure 2 Demonstration of ATP-responsive astroglial Ca
2+ signalling in the NAc slice. A: Time-series of Fluo-4 pseudo-coloured
fluorescence images (see also Additional file 1) show propagation of Ca
2+ transients induced by pressure-ejection of 100 μM ATP onto the
surface of the NAc slice through a 5-10 μm patch-pipette for 60 s (long puff). Time refers to the period passed from the beginning of the long
ATP puff. Arrows indicate the origin and orientation of the ATP puff (red with X) and the direction of ACSF perfusion (white). Scale bar: 50 μm.
B: The area initially covered by the short (left and middle) and long (right) ATP puffs was investigated to observe which cells get a direct ATP
stimulus. Representative images of the glial marker dye SR101 (100 μM dissolved in ACSF; [19,20]) applied together with 100 μM ATP to visualize
propagation of ATP puff above 630 nm using a 543 nm laser for excitation. This was done in parallel with monitoring the ATP-responsive Fluo-4
Ca
2+ transients in the NAc slice. The small azure circle indicates the border of the ATP+SR101 puff for 2 s (short puff) and the big azure circle
shows the margin of the ATP+SR101 diffusion. Yellow circle beyond the small azure circle highlight the cell responded to the short puff
application of ATP. Scale bar: 100 μm. C: Representative (dF/F0)max Fluo-4 fluorescence plot of the cell highlighted by the yellow circled cell in
panel B recorded during ATP application for 2 s (short puff) and for 60 s (long puff, cf. B). D: Number of networking cells in long ATP puff-
stimulated Ca
2+ transients was significantly higher in the NAc when compared to the adjacent ventral pallidal area.
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Ca
2+ with (N = 8 from 4 rats) or without (N = 5 from 4
rats) the intracellular calcium store depleting CPA (10
μM, [18]) or CPA alone (N =5f r o m3r a t s )( F i g u r e4 A
left) suggest that the appearance of concerted Ca
2+ tran-
sients stimulated by ATP in the NAc slice was reliant
on the cellular Ca
2+ stores. Ca
2+ release from internal
stores may also substantiate oscillatory dynamics
observed (see Figure 2C).
In addition to the number of ATP-responsive cells, we
also analysed the magnitude o ft h er e s p o n s e( F i g u r e4 B
and Methods section). Maximal dF/F0 values for indivi-
dual cells in the absence and presence of the test com-
pounds were determined. The calculated average change
in (dF/F0)max values were compared to the Δ(dF/F0)max
values obtained for two consecutive ATP applications
both in the absence of test compounds (control), and
were given as percentage of the first ATP application.
This analysis concluded to results consistent with the
cell number-based evaluation (Figure 4C). The obtained
linear correlation between the cell number- and fluores-
cence intensity-based data (R = 0.94 ± 0.09, Figure 4C)
indicates that the Ca
2+ transients are produced by an
on/off trigger, corroborating Ca
2+ store-operated
mechanisms.
SUC activates Ca
2+ transients in NAc astrocytes
We tested the hypothesis whether, in addition to ATP,
SUC also activates astroglial Ca
2+ signals. This was
explored in measurements of the effect of SUC alone
and in combination with the ATP puff-evoked Ca
2+
transients characterized before. To this end, we applied
the drug testing protocol described before (cf.p r e v i o u s
and Methods sections) enabling the detection of the
SUC-responsive Ca
2+ transients before the second ATP
application. This way, the observation of the SUC-
responsive cells throughou tt h es e c o n dA T Pm a d ep o s -
sible comparison of the spatiotemporal characteristics of
the SUC- and ATP puff-evoked Ca
2+ transients.
Indeed, superfusion of SUC initiated Ca
2+ transients in
a sub-population of NAc astrocytes showing Ca
2+ transi-
ents in response to puffs of ATP (Figure 5A1 left).
Apparently, these superimpositions of cells responding
to ATP and SUC were independent of the site of activa-
tion (cf. different localization and direction of ATP
puff). The temporal relationships of SUC- and ATP-
evoked Ca
2+ transients revealed similar dynamics, as
shown by representative dF/F0 traces (cf.F i g u r e5 A 2
and Figure 2C). Within the same SUC-responsive cells,
Ca
2+ transients appeared longer during ATP application
(Figure 5A2 red and green traces) conjecturing coinci-
dent ATP activation. SUC evoked single (Figure 5A2)
and repetitive Ca
2+ transients, being more frequent with
higher [SUC] (data not shown). Mostly double - but see
orange trace in Figure 5C from Figure 5B images at 75 s
and 120 s - Ca
2+ transients evoked by 50 μM SUC were
observed in only about 10% of slices. Similarity of Ca
2+
dynamics may suggest that SUC-responsive cells could
participate in burst-like Ca
2+ signalling evoked by ATP.
It can be relevant in this respect that the number of
SUC-responsive cells did significantly tend to be higher
after the ATP application (1.3 ± 0.3 vs. 3.2 ± 0.5 cells, p
= 0.042, Mann-Whitney U test).
The change in the number of cells showing SUC-
evoked Ca
2+ transients could be characterised by an
EC50 value of 50-60 μM (Figure 5D, N = 35 from 16
rats). The same measurements on Ca
2+ transients, how-
ever, provided less Δ(dF/F0)max data, the possible reason
why the fluorescence intensity-based evaluation of the
effective concentration for SUC was less conclusive (Fig-
ure 5D). These findings were at variance with the results
of the inhibition of ATP puff-evoked Ca
2+ transients (cf.
Figure 3 Co-localization of ATP-evoked Ca
2+ transients with Cx43 immunostaining in the NAc slice.R e p r e s e n t a t i v ei m a g e so fC a
2+
signalling in response to the long ATP puff (green, left) followed by post-calcium (cf. Methods section) Cx43 immunostaining (red, middle)
demonstrated their co-localization (yellow spots marked with white arrows, right). Scale bar: 50 μm.
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Page 5 of 17Figure 4 Molecular dissection of ATP-evoked burst-like Ca
2+ signalling in the NAc slice. A: Cell number-based profiling. Left - ATP-evoked
of Ca
2+ transients: Effects of gap-junction blockers CBX, FFA; P2 antagonists SUR and MRS2179; Na
+ channel blocker TTX; Ca
2+ store depletor
CPA with/without added external Ca
2+. Right - 2-Me-S-ADP evoked Ca
2+ transients: Effect of MRS2179. B: Fluorescence intensity-based profiling.
Left - ATP-evoked of Ca
2+ transients: Effects of gap-junction blockers CBX, FFA; P2 antagonists SUR and MRS2179; Na
+ channel blocker TTX; Ca
2+
store depletor CPA with/without added external Ca
2+. Right - 2-Me-S-ADP evoked Ca
2+ transients: Effect of MRS2179. C: Correlation of data
obtained through cell number- and fluorescence intensity-based evaluation of Ca
2+ transients. The effects of tested compounds/conditions were
compared to the control using Mann-Whitney with Bonferroni post hoc test (*p < 0.05 and **p < 0.01).
Molnár et al. BMC Neuroscience 2011, 12:96
http://www.biomedcentral.com/1471-2202/12/96
Page 6 of 17Figure 5 SUC and ATP evoke overlaying Ca
2+ transients in NAc astrocytes. A1: Confocal image of SUC-responsive cells (green and red
circled yellow spots) participated in ATP-stimulated concerted Ca
2+ burst (green spots marked by white arrows). Red arrows show directions of
SUC (vertical) and ATP (horizontal with x) applications. Scale bar is 50 μm. A2: Representative (dF/F0)max plots showing effects of 50 μM SUC
alone and with 100 μM ATP puff in A1. Red and green traces correspond to the SUC-responsive cells circled in A1 while gray traces show the
fluorescence changes of cells marked by white arrows in A2. B: Confocal images showing fluorescence of 5 μM Fluo-4 AM loaded cells in NAc
slices during control (left image), 50 μM SUC application (middle images) and washout (right image). Time refers to the fluorescence-time plot
(C). Scale bar is 50 μm. C: (dF/F0)max plots showing Ca
2+ transients in response to 50 μM SUC in the NAc slice. Each coloured trace corresponds
to a Ca
2+ transient circled in (B). D: Comparison of cell number- and fluorescence intensity-based summary plots of the effects of SUC on Ca
2+
fluorescence in rat NAc slices. *p < 0.05 and **p < 0.01 compared to control, +p < 0.05 and ++p < 0.01 compared to 50 μM (Mann-Whitney
with Bonferroni post hoc tests; [3]). E: SUC-responsive repetitive Ca
2+ transients co-localized with astroglial markers. The NAc slice showing SUC-
responsive repetitive Ca
2+ transients was subsequently double-immunostained for astroglial marker proteins GFAP (green, left) and Cx43 (red,
middle) while the observation chamber kept continuously on the stage of the confocal microscope. Our post-Calcium protocol (cf. Methods
section) showed yellow co-localisation of Cx43 and GFAP proteins (right) with a SUC-responsive cell shown in A. Scale bar is 5 μm.
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Page 7 of 17Figure 4), suggesting that in addition to the oscillatory
Ca
2+ dynamics, SUC may also alter fluorescence inten-
sity through some other mechanisms making these data
more vulnerable to the threshold criterion applied (cf.
Methods section).
Next, we asked if Ca
2+ transients evoked by SUC
application were occurred in astrocytes. It has already
been demonstrated that the protocol used here for Fluo-
4 AM loading preferentially labels astrocytes [3,24]. For
further identification of cells displaying SUC-responsive
Ca
2+ transients we applied double immunostaining for
the glial marker proteins GFAP (green, Figure 5E left)
and Cx43 (red, Figure 5E middle). Colocalization of
Cx43 and GFAP proteins (yellow, Figure 5E right) iden-
tified the SUC-responsive cells as astrocytes.
Neurons within the domain of burst-like Ca
2+ signalling
are not activated
In order to see if neurons in the NAc participate in
ATP-stimulated astroglial Ca
2+ transients, we filled
visually identified cells in either the shell or core regions
with Ca
2+ indicator dyes (200 μM Fluo-4 tetrapotassium
salt, [3] or 50 μM Oregon Green 488 BAPTA-1 (OGB-
1) hexapotassium salt, [25]). We monitored intracellular
Ca
2+ changes (Figure 6A green traces) and postsynaptic
currents simultaneously. The cells were identified as
neurons by the appearance of voltage activated fast Na
+
currents during application of a voltage-ramp protocol
(-40 mV to +50 mV). This experimental setup allowed
us to simultaneously image the Ca
2+ signal and monitor
the effects of ATP and/or astrocyte Ca
2+ signalling on
both the post-synaptic currents (cf. also Methods sec-
tion) and the cytosolic Ca
2+ of the reporter neuron.
Although the identified reporter neurons were flooded
by the long ATP puff (cf. Figure 2B right) and sur-
rounded by ATP-responsive NAc astrocytes (Figure 6B
left images), astroglial burst-like Ca
2+ signalling caused
no significant changes in cytosolic Ca
2+ (Figure 6A right
images; N = 15, 11 rats) of these neurons. We measured
neuronal Ca
2+ (Figure 6A right images and green traces)
and spontaneous post-synaptic currents (i.e., amplitude
and frequency) under control, ATP and distinct washout
periods (Figure 6C) and found no significant changes in
any of these parameters (Figure 6C; N = 18 for 10 rats).
Similarly to ATP application (Figure 6C), postsynaptic
currents of neurons within the astroglial Ca
2+ signalling
network did not exhibit significant changes in control
frequency and amplitude (16.3 ± 1.5 pA; 3.0 ± 0.9 Hz)
under 50 μM SUC (17.6 ± 2.9 pA, p > 0.05; 2.7 ± 1.0
Hz, p > 0.05), 50 μM SUC+ATP (18.1 ± 1.8 pA, p >
0.05; 2.6 ± 0.8 Hz, p > 0.05) and washout (16.4 ± 2.8
pA, p > 0.05; 3.0 ± 1.6 Hz, p > 0.05) periods (N =3
from 3 rats, data not shown). These findings supported
our conclusion that NAc neurons did not participate in
astroglial Ca
2+ signalling elicited by ATP and/or SUC.
Discussion
We described that ATP evokes burst-like propagation of
Ca
2+ signals amongst astrocytes in the NAc. We dis-
closed for the first time that SUC does also induce Ca
2+
transients. We will discuss the mechanisms of Ca
2+ sig-
nalling amongst astrocytes in the NAc and their possible
relation to neuronal activity. The potential importance
of metabolites related to brain energy state regulating
Ca
2+ signals will also be speculated.
Intercellular Ca
2+ signalling through Cx43 containing
astrocytes in the NAc
The ATP-evoked burst-like Ca
2+ signal apparently pro-
pagates through astrocytes coupled by gap-junctions
[26-28]. More extensive Ca
2+ signalling in response to
the localized ATP stimuli in the NAc as compared to
n e a r b yb r a i na r e a sm a yp o s s i b l yb ed u et ot h em o r e
abundant presence of Cx43 protein and gap-junctions
thereupon. Our observations also suggest that Cx43
containing gap-junctions participate in burst-like Ca
2+
signalling and were expressed only in astrocytes [29].
Note, however, that co-localization of Cx43 and GFAP
may also be associated with reactive astrocytes [30] or
radial glia [31].
Astroglial burst-like Ca
2+ signals are known to propa-
gate via two mechanisms [26,27]: transfer of cytosolic
inositol (1,4,5)-trisphosphate (IP3) directly from cell to
cell through gap junction channels and release of ATP
onto extracellular purinergic receptors. The CBX-sensi-
tive Ca
2+ signal is coupled with the ATP-triggered
enhancement of IP3 and its diffusion through gap-junc-
tion channels between neighbouring astrocytes [32].
Another possible way of CBX- and FFA-sensitive propa-
gation of the Ca
2+ signal involves sequential activation
of cation channels by ATP that is released through gap-
junction hemichannels into the extracellular space
[33,34]. These CBX-sensitive Ca
2+ waves could be
blocked by SUR, a polysulfonated napthylurea used as a
b r o a ds p e c t r u ma n t a g o n i s ta tp u r i n e - a c t i v a t e dP 2 X
channels and G-protein-coupled P2Y receptors [35-37].
In our experiments SUR (100 μM, 1 mM) did not block
the ATP-activated Ca
2+ bursts significantly, although it
is known to antagonize P2X receptors in the 1-100 μM
range [36]. Nevertheless, our results corroborate pre-
vious data suggesting that SUR, the widely used antago-
nist of the effects of ATP at P2 purinoceptors, also
induces calcium inducible calcium release (CICR) and
increases open channel probability of ryanodine receptor
channels [38-42]. These findings can explain the appar-
ent ineffectiveness of SUR as a P2 antagonist by the
Molnár et al. BMC Neuroscience 2011, 12:96
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Page 8 of 17Figure 6 Neuronal activity is not modified by ATP-responsive astroglial Ca
2+ signalling in the NAc slice. A: Fluo-4/tetrapotassium (200
μM) (upper image, left; red arrow) or OGB-1/hexapotassium (50 μM) (lower image left; red arrow) salt filled neurons (B left or right images) were
distinguished by the presence of the fast Na
+ current in the NAc slice. They did not colocalize (A upper and lower images, right; gray arrows
indicate the orientation of the long ATP puff) with the long ATP puff-induced Ca
2+ transients in NAc astrocytes (white arrows). Representative
gray and green (dF/F0)max traces in A show astroglial and neuronal (B) Ca
2+ fluorescence, respectively. Scale bar is 50 μm. B: Higher
magnification of Fluo-4/tetrapotassium (200 μM) (B left) or OGB-1/hexapotassium (50 μM) (right) filled neurons. Scale bar is 50 μm. C: Summary
of the average values of characteristic properties of postsynaptic currents recorded from neurons in the NAc slice. Currents were recorded at -70
mV holding potential using K-Gluconate-based pipette solution. Peak amplitudes and frequencies of individual currents were averaged
throughout 1-min intervals. Mann-Whitney test used for statistical evaluation of amplitude and frequency variations, neither of them was found
to be significant (18 neurons, 10 slices, 10 rats; p > 0.05).
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Page 9 of 17opposing SUR-induced Ca
2+ enhancements through the
direct activation of intracellular Ca
2+ stores.
In contrast, the blockade of both ATP- and the P2Y1-
selective 2-Me-S-ADP-evoked Ca
2+ transients by the
P2Y1 selective antagonist MRS2179 indicated that the
astroglial burst-like Ca
2+ signal may possibly be evoked
by activation of the P2Y1 receptor subtype in the NAc.
The observed variability in MRS2179 effects may be
related to developmental changes of P2Y1 receptors [43]
resulting through receptor/cell heterogeneity within the
shell/core regions of NAc slices prepared from 10-14
day old rats. In addition, endogenous SUC may have a
co-stimulatory role in ATP-induced astroglial Ca
2+ sig-
nalling and, by (partially) antagonizing the effects of the
P2Y1 inhibitor MRS2179 as observed with human plate-
lets [44], may contribute to the inter-slice/rat variability
observed. It may be significant in this regard, that co-
application of SUC and ATP apparently results in more
durable Ca
2+ transients, conjecturing coincidence
detection.
As discussed before, Ca
2+ store mobilization, underly-
ing propagating astroglial burst-like Ca
2+ transients can
occur via P2Y1 receptor activation in the NAc. Both the
inhibitor profile (blockade by CBX, FFA and Cx43 anti-
body) and dynamics of ATP-evoked Ca
2+ waves suggest
cell-to-cell signalling through the gap-junction-coupled
astrocytes in the NAc. Low FFA efficacy may be due to
the possible enhancement of intracellular Ca
2+ by FFA
acting at type 6 transient receptor potential canonical
channel (TRPC6) [45,46].
As outlined above, the alternative ATP-driven way of
signal propagation [26,27,32-34] may not be excluded
purely on the basis of the apparent lack of SUR block-
ade of ATP-evoked Ca
2+ signals. Binding of CBX to
SUC receptor [4-6], however, could be accounted for
some blockade of ATP-driven Ca
2+ signal propagation
as detailed below.
NAc astrocytes respond to SUC
SUC binding sites have previously been disclosed in rat
forebrain and human NAc membrane homogenates
[4,6], however, their functions have not been assigned
yet. Identity of SUC-sensitive GHB [5] and GHB-sensi-
tive SUC [4] binding sites raised the possibility to relate
SUC and different GHB actions [47-50]. Importantly,
the binding site of GHB/SUC interacts with CBX [4-6],
a blocker of gap-junctions that are major players of
astroglial Ca
2+ signalling [51]. We have also shown pre-
viously that GHB activates intracellular store-dependent
Ca
2+ transients in NAc astrocytes [3]. Here we report,
that SUC induced repetitive Ca
2+ transients occur in a
subpopulation of Cx43
+ and GFAP
+ cells responding to
ATP with burst-like Ca
2+ signals involving gap-junc-
tions. SUC may bind to a purinergic G protein coupled
receptor (GPCR) subtype or some other SUC-responsive
membrane receptor such as SUCNR1 (GPCR91). Inter-
estingly, the SUCNR1 gene is located on chromosome 3
as part of a cluster of seven GPCRs in close vicinity to
the genes for P2Y1 [52]. Also, direct effect of SUC on
gap-junctions cannot be excluded. The SUCNR1 has
recently been shown to regulate cellular functions impli-
cated in renal blood pressure regulation [44,53] and
lipolysis of white adipose tissue [54]. In addition, the
SUCNR1 may also have a role for immunity, hyperglyce-
mia, retinal neovascularization, ischemic liver injury and
hematopoiesis as reviewed recently [44]. The presence
of SUCNR1 has been demonstrated in human platelets
and megakaryocytes [44], in various cells of distal
nephron [55] and in cardiomyocytes [56].
The concentration of SUC in plasma [57-59] increases
with exercise [60], metabolic acidosis [61], hypertension
and metabolic diseases [62] from 5 μMu pt o1 2 5μM.
These data suggest that the tissue concentration of SUC
can be high enough to induce astroglial Ca
2+ transients
characterised by the EC50 value for SUC-responsive cells
within the range of 50-60 μM. Using arachidonic acid,
ADP and SUC as platelet agonists, aggregation in
response to SUC alone was highly variable with only
29% of donors showing a (mostly delayed) platelet
response [44]. In contrast, SUC reproducibly and con-
centration-dependently enhanced platelet aggregation in
response to low concentrations of exogenous ADP [44].
Assuming the presence of SUCNR1 and P2Y1 in astro-
cyte membrane, we conjecture co-stimulatory roles
played by endogenous SUC and ATP within the brain.
Such a coincidence detection performed by astrocytes
could explain why astrocytic Ca
2+ transients may be dra-
matically affected by pathological conditions associated
with intense neuronal firing [63].
Signalling layer independent of neurones
It has been reported, that mechanically evoked astrocytic
Ca
2+ waves mediated by the release of ATP and the
activation of P2 receptors in hippocampal cultures
down-regulate excitatory glutamatergic synaptic trans-
mission in an ATP-dependent manner [64]. Using astro-
cyte-specific inducible transgenic mice (dnSNARE mice),
it has been evidenced that by the release of ATP, which
accumulates as adenosine, astrocytes tonically suppress
synaptic transmission in acutely isolated hippocampal
slices [65]. Causal linkage between reduced activation of
adenosine receptors and surface expression of NMDA
receptors has also been evidenced [[66] and references
cited there]. We assumed therefore, that by using ATP
puff, which may also reduce activity of NAc neurons, we
could isolate ‘autonomous’ astrocytic Ca
2+ signalling.
Indeed, the loading pattern of the Ca
2+ indicator Fluo-4
AM [3,24] and the presence of Cx43 protein in cells
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2+ transients identified
them as astrocytes.
Propagation of the Ca
2+ signal in ellipsoidal and/or
radial waveform at a speed of approximately 10 μm/s in
NAc astrocytes is comparable to the time evolution of
Bergmann glia Ca
2+ transients, as previously recorded
from fixed location in vitro [9,10] and in vivo [7,13].
The similarity suggests both phenomena involve ATP-
triggered release of Ca
2+ from intracellular stores, as
f o u n d .T h et y p eo fg l i a lC a
2+ signalling classified as
bursts persisted after application of TTX in the cerebel-
lar Bergmann glia in vivo [7] and NAc astrocytes in
vitro (this work). Unchanged postsynaptic currents and
an invariable cytosolic Ca
2+ level of neurons within the
astrocyte network that exhibited concerted Ca
2+ bursts
support our conclusion that the ATP evokes astroglial
burst-like Ca
2+ signals independently of neuronal activ-
ity in the NAc. In this respect, ATP/SUC-evoked astro-
cytic Ca
2+ transients differ from the ones dependent on
the metabotropic Glu recptor subtype 5, leading to the
activation of the NR2B subunit containing N-Me-D-Asp
receptors (NMDARs) of medium spiny neurones in the
NAc or the striatum [17]. Our conclusion upholds pre-
v i o u sf i n d i n g sb yu s[ 3 ]a n do t h e r s[ [ 2 8 ] ,r e v i e w e di n
[63]], suggesting the existence of “autonomous” activa-
tion of astroglial Ca
2+ signals. Remarkably, glial Ca
2+
bursting activity observed in the cerebellum of awake,
behaving animal is also found to be independent of neu-
ronal activity [7].
Findings obtained with the NAc model of glia activa-
tion described in this work do not exclude, however,
that Ca
2+ signalling involving ATP/SUC sensing cells
m i g h tb eau n i q u ef e a t u r eo ft h eN A c .W em a ya l s o
assume such a signalling route in other brain areas exhi-
biting extensive Cx43 expression. The way of Ca
2+ sig-
nalling is probably characteristic of a given brain region
[28]. Ca
2+ bursts have been shown in cultured astrocytes
[34], white matter tract [67], cerebellum [7] and cortical
brain slices [28,68,69]. Ca
2+ bursts in the neocortex
depend on gap-junction coupling of astrocytes and are
not influenced by neuronal activity while in the corpus
callosum Ca
2+ signalling requires ATP-release mechan-
ism but not gap-junction expression [28]. These path-
ways are not independent from each other and most
probably linked to the cell types participated in Ca
2+
signalling [19]. In the retina, astrocytic Ca
2+ wave is
dependent on gap-junctions, while the wave propagation
between astrocytes and Müller cells requires ATP-
release mechanism [70]. The expression of the major
gap-junction protein of astrocytes Cx43 influences puri-
nergic receptor expression in the spinal cord astrocytes
[71]. These examples rather support the view that glial
Ca
2+ bursts may represent a signalling layer independent
of neurons.
The issue of independence as opposed to interdepen-
dence of glial and neuronal activities is related to the
question of astrocytic release of signalling molecules
that may also modulate synaptic transmission, a process
called gliotransmission. As outlined before, there are
several indications, that astrocytes do affect synaptic
activity through the release of ATP, Glu, D-Ser, tumour
necrosis factor alpha [[63-66,72] and references cited] or
uptake of Glu [73,74] and GABA [74]. It is to note, that
the physiological relevance of gliotransmission in long-
term potentiation (LTP) was called into question
[[75,76], see also [77] for additional references]. In con-
trast, Ca
2+-dependent release of D-Ser from an astrocyte
affecting NMDAR-dependent plasticity was demon-
strated by clamping internal Ca
2+ in individual astro-
cytes of the CA1 area of the hippocampus [77].
Conclusions
Diverse cellular pathways of astroglial Ca
2+ signals are
differently pronounced in various brain regions and they
can also co-occur. Besides, the initial stimuli are likely a
determinant of the relevant physiological function being
involved.
The findings of the present study describe for the
first time the Ca
2+ signals evoked in astrocytes of the
brain reward area, the nucleus accumbens, by the citric
acid cycle intermediate SUC. We also identify these
SUC-responsive Ca
2+ signals in ATP-evoked burst-like
intercellular Ca
2+ signalling. We provide evidence that
ATP- and SUC-responsive glial Ca
2+ signals are inde-
pendent on neuronal activity therefore apparently
represent a signalling layer independent of NAc
neurons.
ATP-induced calcium responses have previously been
shown in cortical and hippocampal astrocytes whereas
succinate-induced calcium signals had not been
described in astrocytes. This previously unrecognized
glial action of the major cellular energy metabolite SUC
may represent a link between brain energy states and
Ca
2+ signalling in astrocytic networks.
Methods
Ethics statement
Animal care and preparations were in accordance with
the Helsinki declaration, the European Council Directive
of 24 November 1986 (86/609/EEC), the Hungarian
Animal Act 1998, and were associated local guidelines,
as approved by the Institutional Animal Care and Use
Committee (approval ID: MÁB 1.51.4.).
Buffers and test compounds
Slice preparing buffer contained in mM: 250 sucrose, 2
KCl, 1.25 KH2PO4,1 0M g S O 4,2C a C l 2,1 6N a H 2CO3
and 10 glucose. Artificial cerebrospinal fluid (ACSF)
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MgSO4, 2 CaCl2, 16 NaHCO3 and 10 glucose.
The following drugs were applied via the ACSF perfu-
sion: SUC, GHB, CBX, another gap-junction blocker
FFA (purchased from Sigma-Aldrich, Budapest, Hun-
gary); P2X/P2Y receptor antagonist SUR, the P2Y1
receptor antagonist MRS2179, the endoplasmic Ca
2
+-ATPase inhibitor CPA, and TTX (from Tocris, Bristol,
UK). Agonists ATP and 2-Me-S-ADP were locally
applied through a glass micropipette (Sigma-Aldrich,
Budapest, Hungary).
Fluorescence indicators Fluo-4 AM, Fluo-4 tetrapotas-
sium salt, OGB-1 hexapotassium salt, propidium iodide
(PI), SR101 and pluronic acid were purchased from
Molecular Probes (Eugene, USA). Stock solutions of
ester fluorescence indicators prepared in DMSO were
diluted to 0.1% DMSO in the staining solution.
Acute slice preparation and dye loading
Coronal slices from the forebrain through the NAc and
the caudate putamen (CP) were prepared for the ima-
ging experiments. Young, 10-14 day-old male Wistar
rats were decapitated and the brains were quickly
removed. The forebrains were serially cut into 300 μm
thick coronal sections (Vibratome, Technical Products
International Inc., St. Louis, MO, USA). The slices were
collected in ice-cold preparation buffer and incubated
for one hour under humidified gas-mixture carbogen
(5% CO2 + 95% O2) atmosphere in an interface-type
holding chamber containing warmed (35°C) ACSF. After
preincubation in 2% pluronic acid containing ACSF for
2 minutes, slices were further incubated with 5 μM
Fluo-4 AM in ACSF at 35°C in the dark under humidi-
fied carbogen (5% CO2 +9 5 %O 2) atmosphere, for one
hour [3]. In order to monitor cell death, several slices
were exposed to double dye-loading protocol, performed
by adding 7.5 μM PI (excitation: 534 nm, emission: 570-
600 nm) to the Fluo-4 AM containing ACSF. In order
to allow for cleavage of the AM ester group of Fluo-4,
slices were transferred to dye-free ACSF at least 30 min-
utes before the start of the experiment [78].
Confocal imaging and drug testing protocol
We used Fluo-4 AM for quantifying astroglial Ca
2+ con-
centrations in the 100 nM to 1 microM range [3]. Fluo-
4 offers high fluorescence emission due to its greater
absorption near 488 nm, and a large dynamic range for
reporting [Ca
2+]a r o u n daK d(Ca
2+) of 345 nM [79].
Fluorescence recordings of changes in the intracellular
Ca
2+ ion level in cells loaded with Fluo-4 AM were per-
formed, with an upright epifluorescent microscope
(Olympus BX61WI, Olympus, Budapest, Hungary)
equipped with the FluoView300 confocal laser-scanning
system (Olympus, Budapest, Hungary) using 20× (0.5
numerical aperture) or 60 (0.9 numerical aperture)
water immersion objectives (for details, see [3]). Image
acquisition rate was controlled by a computer running
Tiempo software for FluoView300 (Olympus, Budapest,
Hungary).
Freshly isolated slices were transferred to the sub-
merge-type recording chamber mounted on the stage of
the microscope and were superfused with carbogenated
(5% CO2 +9 5 %O 2) ACSF (3 ml/min, room tempera-
ture). Serial scanning of slices were made at 488 nm
excitation wavelengths and emitted green fluorescence
was collected through a 510-530 nm bandpass filter. Ca
2
+ transients were initiated by application of SUC in the
perfusion or by pressure-ejection of 100 μMA T Pi n
ACSF through a glass micropipette (5-10 μm diameter)
on the slice surface. Fluorescence intensity changes
within a 355 × 355 μm field containing approximately
100 Fluo-4 AM loaded cells around the area of the ATP
puff, were followed over a 10-minute interval (2 s/
image).
Two 10-minute-long consecutive recordings were
made from each slice with a 20-minute resting time
between the two recordings. ATP was applied 3 min
after the beginning of each 10-minute-long recording
period. All tested drugs (CBX, FFA, SUR, MRS2179,
CPA, TTX) and/or zero-added Ca
2+ condition were
applied throughout the second 10-minute-long record-
ing period and were present at the time of the second
ATP application. Co-localisation of Ca
2+ transients
evoked by the 1st and the 2nd ATP puffs indicated simi-
larity of Ca
2+ dynamics (Figure 7A), making them
strictly comparable. The number of cells showing Ca
2+
increase at approximately 15-30 μm below the surface
of the NAc slice was also similar in consecutive ATP
applications (44 ± 25 cells, Figure 7B).
Images taken during the ATP application were
summed and the average of images taken during the
control period was subtracted as a background. The
Fluo-4 loaded cells were identified by using custom
written algorithms in Matlab under strict visual control.
The intensity changes in individual cells were calculated
as dF/F0. To identify ATP responsive cells, the standard
deviances of the control periods of the dF/F0 traces
(SDcontrol) were calculated and the traces with (dF/F0)
max,ATP >5 * S D control were selected. The number of cells
with fluorescence intensity changes above the threshold
was counted to determine the number of responsive
cells (N) and the average of their maximal dF/F0 values
((dF/F0)max) during the ATP application period was used
to assess the magnitude of the response. The changes in
N and (dF/F0)max values (ΔNa n dΔ(dF/F0)max, respec-
tively) obtained in the presence of test compounds were
normalized to the corresponding N and (dF/F0)max
values obtained in the absence of the test compounds
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2+ transients evoked by consecutive ATP puffs applied onto the surface of the NAc slice. A: Time series of Ca
2+ transients in
response of the 1st (left, red) and the 2nd (middle, green) ATP-puff applied by pressure-ejection of 100 μM ATP through a 5-10 μM diameter
patch-pipette for 60 s (long puff). Time refers to the time elapsed from the beginning of the ATP applications. Overlaying Ca
2+ transients (right,
yellow) suggest similarity of Ca
2+ dynamics of consecutive ATP puffs. Scale bar is 50 μm. B: Comparison of Ca
2+ signalling after the 1st and 2nd
ATP application in the corpus callosum (N = 4), caudate putamen (N = 18) and NAc (N = 32). Data represent means ± S.E.M. (Mann-Whitney
with Bonferroni post hoc test: *p < 0.05. C: The protocol applied for testing effects of different drugs/conditions on ATP-stimulated Ca
2+
elevations in slices from the NAc. The difference between the two recordings in the number of cells (ΔN) or maximal fluorescence intensity Δ
(dF/F0)max was expressed as the percentage of the effects of the first (control) stimulus (100 μM ATP or 10 μM 2-Me-S-ADP) application.
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responsive cells and their maximal response were
reduced in the second ATP application even if the test
compounds were not present. Therefore to take this
reduction into account, the calculated ΔNa n dΔ(dF/F0)
max values for each condition were compared (ANOVA)
to ΔN and Δ(dF/F0)max values obtained for two consecu-
tive ATP applications both in the absence of test com-
pounds (control in Figure 4).
Data presented are mean ± S.E.M., with N denoting
t h en u m b e ro fs l i c e si nag i v e ne x p e r i m e n t a lc o n d i t i o n .
Statistical analysis was performed using the non-para-
metric Mann-Whitney test with Bonferroni post hoc test
(OriginLab Co., Northampton, UK) and p < 0.05 was
considered statistically significant. If otherwise stated,
the effects of different treatments were compared to the
control.
Electrophysiology
Whole cell patch clamp recordings were performed both
in the shell and the core areas of the NAc by using a
MultiClamp 700A amplifier (Axon CNS, Molecular
Devices, Sunnyvale, California, USA). Signals were low-
pass filtered at 2 kHz and digitized at 10 kHz (Digida-
ta1320A, Axon Instruments). Cells selected by their
visual appearance were identified as neurons by the pre-
sence of voltage activated fast Na
+ currents during
application of a voltage ramp protocol -40 to +50 mV
(pClamp8, Axon Instruments). 6-8 Mc pipettes pulled
from borosilicate glass capillaries were filled with an
intracellular solution (containing in mM: 135 K-Gluco-
nate, 10 NaCl, 0.05 CaCl2, 2 adenosine-triphosphate
Mg
2+ salt, 10 4-(2-hydroxyethyl)piperazine-1-ethanesul-
fonic acid (HEPES); pH 7.3 (set with 1N KOH). In order
to visualize and monitor cytosolic Ca
2+ of patched neu-
rons, 200 μM Fluo-4 tetrapotassium salt or 50 μM
OGB-1 hexapotassium salt (excitation: 488 nm, emis-
sion: 510-530 nm for both dyes) was added to the intra-
cellular solution. Cells (input resistance: 166 ± 13 MΩ)
were clamped to -70 mV without corrections for liquid
junction potential (-15 mV). At this potential inward
spontaneous postsynaptic currents were recorded. If
signs of seal deterioration or cell closure occurred, the
recordings were discarded. The first 10 min of each
recording were used for monitoring stabilization of the
baseline. Then, a 1-minute duration control period, fol-
lowed by ATP application (1 min), and a washout per-
iod (5-10 min) were recorded.
Spontaneous postsynaptic currents (PSCs) were ana-
lyzed using Mini Analysis software (Synaptosoft, Deca-
tur, USA; http://www.synaptosoft.com) in 4 data
segments (1 min, each) recorded prior to, at the ATP
application, washout after ATP application and late-
washout periods. The automatically detected events
(threshold: 10 pA) were verified by visual inspection.
Multiple comparisons were done with the non-para-
metric Mann-Whitney test (OriginLab Co., Northamp-
ton, UK). Statistical significance was defined as p < 0.05.
The data are presented as mean ± S.E.M.
Tissue processing for immunohistochemistry
Adult, male Wistar rats (n = 3) (200-250 g body weight;
Charles Rivers Laboratories, Hungary) were deeply
anesthetized with a mixture containing 0.2 ml/300 g b.
w. ketamine (100 mg/ml) and 0.2 ml/300 g b.w. xylazine
(20 mg/ml), and perfused transcardially with 150 ml sal-
ine followed by 300 ml of ice-cold 4% paraformaldehyde
in phosphate buffer, pH 7.0 (PB). Brains were removed
and postfixed in the same fixative solution for 24 h, and
transferred to PB containing 20% sucrose for 2 days.
Serial coronal sections were cut at 50 μm on a sliding
microtome (SM 2000R, Leica Microsystems, Nussloch,
Germany) between +4.0 mm to 0 mm from the level of
the bregma. Sections were collected in PB containing
0.1% sodium azide and stored at 4°C until further
processing.
Cx43 immunohistochemistry
Free-floating sections were immunolabeled for Cx43
using an affinity-purified rabbit polyclonal antiserum
raised against the carboxy terminal 362-382 peptide seg-
ment KPSSRASSRASSRPRPDDLEI of Cx43 (Abcam,
Cambridge, UK, catalogue number: ab11370). Brain sec-
tions were pretreated in PB containing 0.5% Triton X-
100 and 3% bovine serum albumin for 1 h. Then, they
were incubated with a primary antibody against Cx43
(1:1250) in PB containing 0.5% Triton X-100 and 3%
bovine serum albumin and 0.1% sodium azide for 48 h
at room temperature. Sections were then incubated in
biotin-conjugated donkey anti-rabbit secondary antibody
at 1:1000 (Jackson Immunoresearch, West Grove, PA)
for 2 h, followed by incubation in avidin-biotin-horse-
radish peroxidase complex (ABC) at 1:500 (Vectastain
ABC Elite kit, Vector Laboratories, Burlingame, CA) for
2 h. Then, sections were treated with either 0.02% dia-
minobenzidine (Sigma) or fluorescein isothiocyanate
(FITC)-tyramide (1:8000) with 0.003% H2O2 in Tris-HCl
buffer (0.05 M, pH 8.2) for 6 min. After washing, the
sections were mounted on positively charged slides
(Superfrost Plus, Fisher Scientific) and coverslipped with
either Cytoseal 60 (Stephens Scientific, Riverdale, NJ,
USA) or in antifade medium (Prolong Antifade Kit,
Molecular Probes).
Cx43 and GFAP double immunohistochemistry
Free-floating sections were first immunolabeled for
Cx43 using FITC-tyramide amplification immunohisto-
chemistry, as described above. Then, sections were
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Page 14 of 17incubated overnight in a mouse monoclonal anti-GFAP,
a marker of astrocytes (1:250; catalogue number: sc-
33673, Santa Cruz Biotechnology, Santa Cruz, CA). Sub-
sequently, sections were incubated in Alexa 594 donkey
anti-mouse secondary antibody (1:500; Molecular Probes)
for 2 h, then mounted and coverslipped, as described
above. Sections were examined using an Olympus BX60
light microscope also equipped with fluorescent epi-illu-
mination. Images were captured at 2048 × 2048 pixel
resolution with a SPOT Xplorer digital CCD camera
(Diagnostic Instruments, Sterling Heights, MI) using 4-
20× objectives. Confocal images were acquired with a
Nikon Eclipse E800 confocal microscope equipped with a
BioRad Radiance 2100 Laser Scanning System using 20-
60× objectives (at an optical thickness of 1-3 μm). Con-
trast and sharpness of the images were adjusted using the
“levels” and “sharpness” commands in Adobe Photoshop
CS 8.0. Colours were adjusted so that Cx43 appeared red
and GFAP was green. Full resolution was maintained
until the photomicrographs were cropped and assembled
for printing, at which point images were adjusted to a
resolution of 300 dpi.
Post-calcium imaging immunohistochemistry protocol for
Cx43 and GFAP
In order to identify the cell types involved in Ca
2+
bursts, the brain slices were immunostained with antibo-
dies for astrocyte marker proteins (Cx43 and GFAP).
However, Fluo-4 signal could not be preserved through
fixation with either 0.4% paraformaldehyde or 40 mg/ml
EDAC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide,
Sigma-Aldrich; Dawling and Deitmer, 2002). Therefore,
co-localization between SUC/ATP-responsive cells and
cell type markers could not be resolved. Hence we
opted to perform the in situ immunostaining in non-
fixed slices directly after the Ca
2+ imaging protocol.
Slices used previously to measure Ca
2+ changes in
response to SUC/ATP application were treated as fol-
lows: upon completion of the calcium-imaging experi-
ments, each slice was kept in its original position in the
recording chamber (using a ballast) and incubated with
Cx43 (1:300) and GFAP (1:200) primary antibodies for
30 min, at room temperature. After 3 × 10 minute
washing in ACSF, the slice was incubated with Chromeo
546 goat anti-rabbit (1:100 Abcam, Cambridge, UK, cat-
alogue number: ab60317) secondary antibody and Alexa
488 donkey anti-mouse (1:100, Molecular Probes) sec-
ondary antibody in ACSF for 30 min, at room tempera-
ture. This was followed by 3 × 10 minute washing in
ACSF. Serial Z-scans of Cx43- (excitation: 543 nm,
emission: 570-600 nm) and GFAP- (excitation: 488 nm,
emission: 510-530 nm) labelled slices were acquired
between the slice surface and the maximal penetration
depth of the antibodies (approximately 60-70 μmf r o m
the surface) through a 20× objective (1 μm/step). Since
the fluorescence emission of both Fluo-4 and Alexa-488
dyes are collected in the 510-530 nm range, GFAP-spe-
cific staining was obtained by subtracting the Fluo-4
fluorescence from the GFAP immunolabelling signal, at
each Z depth. Optical sections from identical depths of
Fluo-4 and Cx43 images were merged along the Z axis.
Single cells and glia filaments that showed double
immunolabelling were recorded through a 60× objective
and Z-scans were performed by alternating the excita-
tion wavelengths between 543 nm (Cx43) and 488 m
(GFAP) using Tiempo software for FluoView300, at
each depth (0.1 μm/step). Images were processed using
ImageJ 1.44 [80] and Adobe Photoshop CS 8.0 image
analysis software.
Additional material
Additional file 1: Ca
2+ signalling evoked by ATP in the acute NAc
slice from the rat brain. Movie of time measurement showing ATP (100
μM) application onto a Fluo-4 AM loaded acute NAc slice (300 μm). ATP
was applied for 60 s (long puff) through a glass micropipette right above
the tissue surface. Image acquisition frequency was 2 s in depth of 25
μm from the slice surface. Olympus FluoView300 software collected .tiff
file stacks were coloured and converted to .avi file by ImageJ 1.44 (32-
bit) image processing and analysis software [80]. ATP-responsive cells
were counted by using an ImageJ macro developed to average stacks
before the time of ATP application and to subtract this average from
every stack of the 10 minute-long recording. In this way, we got a 10-
minute-long movie showing only the cells that had a fluorescence
intensity change.
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